BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8297793)

  • 1. c-Myc induces the expression and activity of ornithine decarboxylase.
    Wagner AJ; Meyers C; Laimins LA; Hay N
    Cell Growth Differ; 1993 Nov; 4(11):879-83. PubMed ID: 8297793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
    Packham G; Cleveland JL
    Oncogene; 1997 Sep; 15(10):1219-32. PubMed ID: 9294616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs.
    Tobias KE; Shor J; Kahana C
    Oncogene; 1995 Nov; 11(9):1721-7. PubMed ID: 7478599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
    Voskas D; Mader R; Lee J; Hurta RA
    Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
    Hurta RA; Lee J; Voskas D
    J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of c-myc and ornithine decarboxylase expression by distinct protein kinase systems in IL-3-dependent myeloid cells.
    Farrar WL; Willette-Brown J; Linnekin D
    Lymphokine Cytokine Res; 1991 Aug; 10(4):291-9. PubMed ID: 1718453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of CPP32/Caspase-3 in c-Myc-induced apoptosis.
    Kangas A; Nicholson DW; Hölttä E
    Oncogene; 1998 Jan; 16(3):387-98. PubMed ID: 9467964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
    Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
    Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-modulation of c-myc expression by phorbol ester protects CEM T leukaemia cells from starvation-induced apoptosis: role of ornithine decarboxylase and polyamines.
    Tiberio L; Maier JA; Schiaffonati L
    Cell Death Differ; 2001 Oct; 8(10):967-76. PubMed ID: 11598794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor and c-Myc transcription factors as putative partners in the in vivo cross-talk between androgen receptor-mediated and c-Met-mediated signalling pathways.
    Dudkowska M; Jaworski T; Grzelakowska-Sztabert B; Manteuffel-Cymborowska M
    Acta Biochim Pol; 2007; 54(2):253-9. PubMed ID: 17520086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid expression of ornithine decarboxylase mRNA in a macrophage-like cell line: cAMP repression of the requirement for prior protein synthesis.
    Shurtleff SA; McElwain CM; Taffet SM
    J Cell Physiol; 1988 Mar; 134(3):453-9. PubMed ID: 2832424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
    Nilsson JA; Keller UB; Baudino TA; Yang C; Norton S; Old JA; Nilsson LM; Neale G; Kramer DL; Porter CW; Cleveland JL
    Cancer Cell; 2005 May; 7(5):433-44. PubMed ID: 15894264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-cycle progression is not essential for c-Myc to block differentiation.
    Ryan KM; Birnie GD
    Oncogene; 1997 Jun; 14(23):2835-43. PubMed ID: 9190900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Position and orientation independent transactivation by c-Myc.
    Packham G; Bello-Fernandez C; Cleveland JL
    Cell Mol Biol Res; 1994; 40(7-8):699-706. PubMed ID: 7787888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
    Hurta RA; Greenberg AH; Wright JA
    J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression.
    Moshier JA; Dosescu J; Skunca M; Luk GD
    Cancer Res; 1993 Jun; 53(11):2618-22. PubMed ID: 8495425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells.
    Lin CK; Zou HY; Kaptein JS; Yen CF; Kalunta CI; Nguyen TT; Park E; Lad PM
    Exp Cell Res; 1997 Nov; 237(1):231-41. PubMed ID: 9417887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hnRNP U interacts with the c-Myc-Max complex on the E-box promoter region inducing the ornithine decarboxylase gene.
    Matsuoka Y; Uehara N; Tsubura A
    Oncol Rep; 2009 Aug; 22(2):249-55. PubMed ID: 19578763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of ornithine decarboxylase induction by deguelin, a natural product cancer chemopreventive agent.
    Gerhauser C; Lee SK; Kosmeder JW; Moriarty RM; Hamel E; Mehta RG; Moon RC; Pezzuto JM
    Cancer Res; 1997 Aug; 57(16):3429-35. PubMed ID: 9270009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
    Lepique AP; Moraes MS; Rocha KM; Eichler CB; Hajj GN; Schwindt TT; Armelin HA
    J Mol Endocrinol; 2004 Dec; 33(3):623-38. PubMed ID: 15591023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.